Danimer Scientific Q2 2024 GAAP EPS $(0.19) Beats $(0.24) Estimate, Sales $7.628M Miss $9.270M Estimate
Portfolio Pulse from Benzinga Newsdesk
Danimer Scientific (NYSE:DNMR) reported Q2 2024 GAAP EPS of $(0.19), beating the $(0.24) estimate, but sales of $7.628M missed the $9.270M estimate. EPS improved by 50% YoY, while sales decreased by 40.71% YoY.
August 08, 2024 | 8:04 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Danimer Scientific's Q2 2024 GAAP EPS of $(0.19) beat estimates, showing a significant improvement in earnings. However, sales of $7.628M missed expectations and declined significantly YoY.
While the EPS beat indicates improved profitability, the significant miss on sales and YoY decline in revenue could offset positive sentiment. The mixed results are likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100